Topic: awareness campaigns
A year after tapping a former Yankees star for its "Breathless" push, Boehringer Ingelheim had another surprise for baseball fans this opening day.
Drug materials are targets of U.S.-China trade war, analysts see more hope in the Takeda-Shire deal, China puts forward policies that favors generics over brands.
Boehringer Ingelheim wants to move its drug nintedanib into the scleroderma market. Meanwhile, it’s working to expand awareness of the disease, too.
Alnylam highlights the power of family in hereditary diseases, putting the spotlight on one extended family in its new disease awareness campaign.
IPF patients often say they don't feel "sick enough" for treatment, so Boehringer is aiming to show doctors the benefits of early intervention.
While unbranded pharma ads can be easier to pull off—or at least easier to get through medical and legal review—the same marketing rules apply.
COPD can be genetic. So Wednesday, on Rare Disease Day, Grifols is launching an awareness campaign to encourage COPD patients to get tested.
AbbVie’s new awareness campaign Speak Endo centers on the "hammering" and "stabbing" pains that come with endometriosis.
Inspiring hope for Alzheimer’s caregivers is the mission for Allergan's new campaign.
One of AbbVie's latest TV ads for IBD awareness doesn't use any words, but that hasn't stopped it from creating controversy.